Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 59

1.

The stability of CREB3/Luman is regulated by protein kinase CK2 phosphorylation.

Schmitt BM, Ampofo E, Stumpf H, Montenarh M, Götz C.

Biochem Biophys Res Commun. 2020 Jan 12. pii: S0006-291X(20)30076-0. doi: 10.1016/j.bbrc.2019.12.118. [Epub ahead of print]

PMID:
31941600
2.

Development of an in vitro screening assay for PIP5K1α lipid kinase and identification of potent inhibitors.

Strätker K, Haidar S, Amesty Á, El-Awaad E, Götz C, Estévez-Braun A, Jose J.

FEBS J. 2019 Dec 26. doi: 10.1111/febs.15194. [Epub ahead of print]

PMID:
31876381
3.

Protein Kinase CK2-A Putative Target for the Therapy of Diabetes Mellitus?

Ampofo E, Nalbach L, Menger MD, Montenarh M, Götz C.

Int J Mol Sci. 2019 Sep 7;20(18). pii: E4398. doi: 10.3390/ijms20184398. Review.

4.

Cyclin-Dependent Kinase 5 (CDK5)-Mediated Phosphorylation of Upstream Stimulatory Factor 2 (USF2) Contributes to Carcinogenesis.

Chi TF, Horbach T, Götz C, Kietzmann T, Dimova EY.

Cancers (Basel). 2019 Apr 12;11(4). pii: E523. doi: 10.3390/cancers11040523.

5.

Design of CK2β-Mimicking Peptides as Tools To Study the CK2α/CK2β Interaction in Cancer Cells.

Lindenblatt D, Horn M, Götz C, Niefind K, Neundorf I, Pietsch M.

ChemMedChem. 2019 Apr 17;14(8):833-841. doi: 10.1002/cmdc.201800786. Epub 2019 Mar 12.

PMID:
30786177
6.

Ecto-protein kinase CK2, the neglected form of CK2.

Montenarh M, Götz C.

Biomed Rep. 2018 Apr;8(4):307-313. doi: 10.3892/br.2018.1069. Epub 2018 Feb 21. Review.

7.

A π-Halogen Bond of Dibenzofuranones with the Gatekeeper Phe113 in Human Protein Kinase CK2 Leads to Potent Tight Binding Inhibitors.

Schnitzler A, Gratz A, Bollacke A, Weyrich M, Kuckländer U, Wünsch B, Götz C, Niefind K, Jose J.

Pharmaceuticals (Basel). 2018 Feb 17;11(1). pii: E23. doi: 10.3390/ph11010023.

8.

Functional interplay between the transcription factors USF1 and PDX-1 and protein kinase CK2 in pancreatic β-cells.

Spohrer S, Groß R, Nalbach L, Schwind L, Stumpf H, Menger MD, Ampofo E, Montenarh M, Götz C.

Sci Rep. 2017 Nov 27;7(1):16367. doi: 10.1038/s41598-017-16590-0.

9.

Quinalizarin inhibits adipogenesis through down-regulation of transcription factors and microRNA modulation.

Schwind L, Nalbach L, Zimmer AD, Kostelnik KB, Menegatti J, Grässer F, Götz C, Montenarh M.

Biochim Biophys Acta Gen Subj. 2017 Dec;1861(12):3272-3281. doi: 10.1016/j.bbagen.2017.09.018. Epub 2017 Sep 28.

PMID:
28964816
10.

Impact of protein kinase CK2 inhibitors on proliferation and differentiation of neural stem cells.

Bender M, Schwind L, Grundmann D, Martin M, Klotz M, Götz C, Montenarh M, Schäfer KH.

Heliyon. 2017 Jun 9;3(6):e00318. doi: 10.1016/j.heliyon.2017.e00318. eCollection 2017 Jun.

11.

The mammalian STE20-like kinase 1 (MST1) is a substrate for the apoptosis inhibiting protein kinase CK2.

Servas C, Kiehlmeier S, Hach J, Gross R, Götz C, Montenarh M.

Cell Signal. 2017 Aug;36:163-175. doi: 10.1016/j.cellsig.2017.05.005. Epub 2017 May 6.

PMID:
28487119
12.

Protein kinase CK2 in development and differentiation.

Götz C, Montenarh M.

Biomed Rep. 2017 Feb;6(2):127-133. doi: 10.3892/br.2016.829. Epub 2016 Dec 19.

13.

Identification of a Potent Allosteric Inhibitor of Human Protein Kinase CK2 by Bacterial Surface Display Library Screening.

Nienberg C, Garmann C, Gratz A, Bollacke A, Götz C, Jose J.

Pharmaceuticals (Basel). 2017 Jan 5;10(1). pii: E6. doi: 10.3390/ph10010006.

14.

The Phosphorylation of PDX-1 by Protein Kinase CK2 Is Crucial for Its Stability.

Klein S, Meng R, Montenarh M, Götz C.

Pharmaceuticals (Basel). 2016 Dec 28;10(1). pii: E2. doi: 10.3390/ph10010002.

15.

Corrigendum: Protein kinases as switches for the function of upstream stimulatory factors: implications for tissue injury and cancer.

Horbach T, Götz C, Kietzmann T, Dimova EY.

Front Pharmacol. 2016 Apr 5;7:92. doi: 10.3389/fphar.2016.00092. eCollection 2016.

16.

The nuclear fraction of protein kinase CK2 binds to the upstream stimulatory factors (USFs) in the absence of DNA.

Spohrer S, Dimova EY, Kietzmann T, Montenarh M, Götz C.

Cell Signal. 2016 Feb;28(2):23-31. doi: 10.1016/j.cellsig.2015.11.007. Epub 2015 Nov 11.

PMID:
26577526
17.

A scent of therapy: Synthetic polysulfanes with improved physico-chemical properties induce apoptosis in human cancer cells.

Allah DR, Schwind L, Asali IA, Nasim J, Jacob C, Götz C, Montenarh M.

Int J Oncol. 2015 Sep;47(3):991-1000. doi: 10.3892/ijo.2015.3093. Epub 2015 Jul 20.

PMID:
26201476
18.

Functional display of heterotetrameric human protein kinase CK2 on Escherichia coli: a novel tool for drug discovery.

Gratz A, Bollacke A, Stephan S, Nienberg C, Le Borgne M, Götz C, Jose J.

Microb Cell Fact. 2015 Jun 3;14:74. doi: 10.1186/s12934-015-0263-z.

19.

Protein kinase CK2 is necessary for the adipogenic differentiation of human mesenchymal stem cells.

Schwind L, Wilhelm N, Kartarius S, Montenarh M, Gorjup E, Götz C.

Biochim Biophys Acta. 2015 Oct;1853(10 Pt A):2207-16. doi: 10.1016/j.bbamcr.2015.05.023. Epub 2015 May 27.

20.

Protein kinases as switches for the function of upstream stimulatory factors: implications for tissue injury and cancer.

Horbach T, Götz C, Kietzmann T, Dimova EY.

Front Pharmacol. 2015 Feb 18;6:3. doi: 10.3389/fphar.2015.00003. eCollection 2015. Erratum in: Front Pharmacol. 2016;7:92.

Supplemental Content

Loading ...
Support Center